Immunicum AB (publ) has signed a research agreement with Rutgers Cancer Institute of New Jersey, in USA to supply the institution with the Company’s adenovirus (Ad5PTDf35) technology.
Read the press release here: Press release 150907 – Rutgers Cancer Institute
Notice: Theme without comments.php is deprecated since version 3.0.0 with no alternative available. Please include a comments.php template in your theme. in /home/i/immunicu/www/wp-includes/functions.php on line 4805